Phase III HCVerso™ trial design focuses on genotype-1b patients following positive Phase IIb data in this population


INGELHEIM, Germany - Thursday, January 17th 2013 [ME NewsWire]

(BUSINESS WIRE)-- For media outside of the U.S.A., UK and Canada only

Today, Boehringer Ingelheim announced that the first patients have been enrolled in the company’s pivotal Phase III interferon (IFN)-free hepatitis C (HCV) clinical trial programme, HCVerso™. Boehringer Ingelheim’s IFN-free investigational polymodal* regimen combines faldaprevir (BI 201335)+, a next wave once-daily protease inhibitor, and BI 207127+, a non-nucleoside polymerase inhibitor, plus ribavirin.

The HCVerso™ clinical trial programme includes two Phase III IFN-free clinical trials that will treat approximately 1,000 treatment-naïve HCV genotype-1b (GT-1b) patients.1,2The decision to focus the Phase III trials on this patient group follows positive Phase IIb trial data from the SOUND-C studies, where B ... Read more »

ATLANTA - Thursday, January 17th 2013 [ME NewsWire]

(BUSINESS WIRE)-- SIPCO, LLC is pleased to announce that SmartLabs, Inc., a leader in automation and control technology, has become a proud member of the Essential Wireless MeshTMPatent Portfolio by taking a license to SIPCO’s patents, including U.S. Patent Numbers 7,103,511; 6,437,692; and 7,697,492.

About SIPCO, LLC

SIPCO is a leading innovator of mesh networking and related technology based in Atlanta, Georgia. Founded by renowned inventor T. David Petite, SIPCO developed technologies enabling robust self-organizing wireless networking and related technologies known as Wireless Mesh in conjunction with IntusIQ. Wireless Mesh is used in protocols such as ZigBee, Z-Wave, IEEE 802.15.4, WirelessHART and proprietary mesh network and in other wireless applications such as SmartGrid, building automation, industrial controls, network backhaul, smart vehicles, home appliances, home automation and entertainment, sensor ... Read more »

Dubai, United Arab Emirates - Thursday, January 17th 2013 [ME NewsWire]

 The 1st Arab World Conference on Public Health, promises to bring together leaders in public health from different Arab countries as well as health experts across the globe to discuss critical issues in Public Health in the region.

The congress will be held under the patronage of Dubai Health Authority in collaboration with the World Federation of Public Health Associations and supported by Health Minister’s Council for Cooperative Council States and Emirate Medical Association at Ritz Carlton Hotel in Dubai from 4th until 6th April 2013.

Dubai Health Authority aims to promote the theme of the congress - ‘Towards excellence in Public Health: Opportunities and Challenges in the Arab World’ in order to bring the Arab World together in public health services and in minimizing disparity.

Ms. Laila Al Jassmi, Chairperson of the steering committee, CEO - Health Policy and Strategy Sector ... Read more »

Cette lampe permet de réduire d'un tiers le point de commutation par rapport aux produits existants

TOKYO - Samedi 19 Janvier 2013 [ME NewsWire]

(BUSINESS WIRE)--Toshiba Corporation (TOKYO : 6502) a lancé une nouvelle lampe stroboscopique autonome pour transistors bipolaires à grille isolée (IGBT) destinée aux appareils photos numériques, qui réduit d'un tiers le point de commutation par rapport aux produits existants de Toshiba. Le nouveau IGBT GT5G134 a été développé comme une solution spécifique pour le contrôle de l'intensité de flash et les applications flash photo à grande vitesse de commutation.
 

Fonctionnalités principales

1.
          

Commutation à haute vitesse : tf = 0,6 μs (typ.) @IC= 110 A

2.
          

Tension basse saturation : VCE(sat) = 2,2 V (ty ... Read more »

Reduces switching time to one-third of existing product

TOKYO - Thursday, January 17th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Toshiba Corporation (TOKYO:6502) has launched a discrete IGBT for the strobe lighting of digital cameras that reduces switching time to one-third that of Toshiba's current product. The new IGBT, "GT5G134", was developed as a dedicated solution for photo-flash intensity control and high-speed-switching photo flash applications.
 

Key Features

1.
          

High-speed switching: tf = 0.6µs (typ.) @IC=110A

2.
          

Low saturation voltage: VCE(sat) = 2.2V (typ.) @IC=110A

3.
          

Low gate driving voltage: VGE = 4.0V (min.) @IC=110A

4.
          

Peak collector current: ICP = 110A (max)

5.
       ... Read more »

New research programme unveiled by Boehringer Ingelheim and the European Foundation for the Study of Diabetes (EFSD) invites European diabetes research projects to apply for funding

INGELHEIM, Germany - Thursday, January 17th 2013 [ME NewsWire]

(BUSINESS WIRE)-- The Boehringer Ingelheim and EFSD diabetes partnership has opened submissions for diabetes research grant applications from across Europe. In a collaboration which aims to stimulate and accelerate European research in diabetes, the EFSD/Boehringer Ingelheim European Diabetes Research Programmes have dedicated more than 2.5 million euros over three years to support research projects targeting specific areas of interest.

"Diabetes affects more than 371 million people worldwide and diabetes remains undiagnosed in up to 50% of cases,” said Prof. Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim. "We are delighted to partner with the EFSD on this initiative and hope the grant encourages ... Read more »